Agilent Technologies, Inc. (A)

Market Cap	34.76B -17.2%
Revenue (ttm)	6.95B +6.7%
Net Income	1.30B +1.1%
EPS	4.57 +3.2%
Shares Out	282.84M
PE Ratio	26.89
Forward PE	20.71
Dividend	$1.02 (0.83%)
Ex-Dividend Date	Mar 31, 2026

Volume	4,242,651
Open	125.20
Previous Close	126.34
Day's Range	122.06 - 125.80
52-Week Range	96.43 - 160.27
Beta	1.30
Analysts	Buy
Price Target	165.13 (+34.36%)
Earnings Date	Feb 25, 2026

About A

Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates through three segments: Life Sciences and Diagnostics Markets, Agilent CrossLab, and Applied Markets. The Life Sciences and Diagnostics Markets segment offers liquid chromatography systems and components; and liquid chromatography mass spectrometry systems. This segment is also involved in the genomics, contract development and manufacturing organization, pathology, companion diagnosti...

• Industry: Diagnostics & Research
• Sector: Healthcare
• IPO Date: Nov 18, 1999
• Employees: 18,100
• Stock Exchange: NYSE
• Ticker Symbol: A
• Website: https://www.agilent.com

Financial Performance

In fiscal year 2025, Agilent Technologies's revenue was $6.95 billion, an increase of 6.73% compared to the previous year's $6.51 billion. Earnings were $1.30 billion, an increase of 1.09%.

Analyst Summary

According to 16 analysts, the average rating for A stock is "Buy." The 12-month stock price target is $165.13, which is an increase of 34.36% from the latest price.

Price Target

$165.13

(34.36% upside)

Analyst Consensus: Buy